Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00041730
Status:
UNKNOWN
Last Update Posted:
2009-09-30
First Post:
2002-07-15
Brief Title:
Rituxan Plus FavId Idiotype Vaccine for Low-grade Non-Hodgkins Lymphoma
Sponsor:
Favrille
Organization:
Favrille